This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sica, D. A Search for Related Content PubMed PubMed Citation Articles by Sica, D. A Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

The pharmacology of agents that interfere with renin-angiotensin system activity

Division of Nephrology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, USA

References

• Sica DA Newer antihypertensive agents: Angiotensin-receptor antagonists and aldosterone receptor antagonists. In: Atlas of Hypertension. Hollenberg N (Ed) (5th edition). Current Medicine, Inc. Philadelphia, PA. 2005:326-50.
• Sica DA, Gehr TW, Ghosh S. Clinical pharmacokinetics of losartan. Clin Pharmacokinet 2005;44:797-814.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Gleiter CH, Morike KE Clinical pharmacokinetics of candesartan. Clin Pharmacokinet 2002;41:7-17.[Web of Science][Medline] [Order article via Infotrieve]
• Mire DE, Silfani TN, Pugsley MK A review of the structural and functional features of olmesartan medoxomil, an angiotensin receptor blocker. J Cardiovasc Pharmacol 2005;46:585-93.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sica DA Renal handling of angiotensin receptor blockers: clinical relevance. Curr Hypertens Rep 2003;5:337-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sica DA Angiotensin receptor blockers - new considerations in their mechanism of action. J Clinical Hypertension 2006;8;381-5.[CrossRef]
• Maillard MP, Wurzner G., Nussberger J. et al. Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing. Clin Pharmacol Ther 2002;71:68-76.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• White WB, Lacourciere Y., Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. Am J Hypertens 2004; 17:347-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Weisser B., Gerwe M., Braun M., Funken C. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals] Arzneimittelforschung 2005;55:505-13.[Medline] [Order article via Infotrieve]
• Sica DA, Gehr TWB, Frishman WH The renin-angiotensin axis: Angiotensin converting enzyme inhibitors and angiotensin-receptor blockers. In: Frishman W, Sonnenblick S, Sica DA (eds.) Cardiovascular Pharmacotherapeutics (2nd edition). New York, NY: McGraw-Hill. 2003: pp. 131-56.
• Leblanc JM, Dasta JF, Pruchnicki MC, Schentag JJ Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors. J Clin Pharmacol 2006;46:968-80.[Abstract/Free Full Text]
• Dzau VJ, Bernstein K., Celermajer D. et al. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 2001;88 (suppl 9):1L-20L.[Web of Science][Medline] [Order article via Infotrieve]
• Rahuel J., Rasetti V., Maibaum J. et al. Structure-based drug design: the discovery of novel non peptide orally active inhibitors of human renin. Chem Biol 2000;7:493-504.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nussberger J., Wuerzner G., Jensen C., Brunner HR Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100): comparison with enalapril. Hypertension 2003;39:E1-E8.[CrossRef][Web of Science]
• Azizi M., Webb R., Nussberger J., Hollenberg NK Renin inhibition with aliskiren: where are we now and where are we going? J Hypertens 2006;24:243-56.[Web of Science][Medline] [Order article via Infotrieve]
• Zhao C., Vaidyanathan S., Yeh CM et al. Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus. Clin Pharmacokinet 2006;45:1125-34.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Vaidyanathan S., Limoges D., Yeh C., Dieterich H. Aliskiren, an orally effective renin inhibitor, shows dose linear pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 2006;79:64(PIII-23).
• Vaidyanathan S., Jin Y., Schiller H., Jensen C. Aliskiren, a novel oral renin inhibitor, has no interaction with cytochrome P450 isoenzymes in vitro. Bas Clin Pharmacol Toxicol;97(suppl 1).
• Gradman AH, Schmieder RE, Lins RL et al. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation 2005;111: 1012-18.[Abstract/Free Full Text]
• Sica D., Gradman A., Lederballe I. et al. Aliskiren, an oral renin inhibitor, provides long-term antihypertensive efficacy and safety in patients with hypertension. Eur Heart J 2006;27(suppl):P797.
• Feldman DL, Persohn E., Schutz H. et al. Renal localization of the renin inhibitor aliskiren. J Clin Hypertens 2006;8 (suppl A):A80.
• Herron J., Mitchell J., Oh B. et al. The novel renin inhibitor aliskiren is not associated with rebound effects on blood pressure or plasma renin activity following treatment withdrawal. J Clin Hypertens 2006;8(suppl A):A86.[CrossRef]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 4, 247-250 (2006)
DOI: 10.3317/jraas.2006.046


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sica, D. A Search for Related Content PubMed PubMed Citation Articles by Sica, D. A Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?